Publication:
Proteomic Study of the Interactions between Phages and the Bacterial Host Klebsiella pneumoniae

dc.contributor.authorBleriot, Inés
dc.contributor.authorBlasco, Lucia
dc.contributor.authorPacios, Olga
dc.contributor.authorFernández-García, Laura
dc.contributor.authorLópez, María
dc.contributor.authorOrtiz-Cartagena, Concha
dc.contributor.authorBarrio-Pujante, Antonio
dc.contributor.authorFernández-Cuenca, Felipe
dc.contributor.authorPascual, Álvaro
dc.contributor.authorMartínez-Martínez, Luis
dc.contributor.authorOteo-Iglesias, Jesus
dc.contributor.authorTomás, María
dc.contributor.authorGEMARA (SEIMC)
dc.contributor.funderPlan Nacional de I+D+i (España)
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)
dc.contributor.funderRETICS-Investigación en Patología Infecciosa (REIPI-ISCIII) (España)
dc.contributor.funderCentro de Investigación Biomédica en Red - CIBERINFEC (Enfermedades Infecciosas)
dc.contributor.funderXunta de Galicia (España)
dc.date.accessioned2023-07-17T15:25:01Z
dc.date.available2023-07-17T15:25:01Z
dc.date.issued2023-03-06
dc.description.abstractPhages and bacteria have acquired resistance mechanisms for protection. In this context, the aims of the present study were to analyze the proteins isolated from 21 novel lytic phages of Klebsiella pneumoniae in search of defense mechanisms against bacteria and also to determine the infective capacity of the phages. A proteomic study was also conducted to investigate the defense mechanisms of two clinical isolates of K. pneumoniae infected by phages. For this purpose, the 21 lytic phages were sequenced and de novo assembled. The host range was determined in a collection of 47 clinical isolates of K. pneumoniae, revealing the variable infective capacity of the phages. Genome sequencing showed that all of the phages were lytic phages belonging to the order Caudovirales. Phage sequence analysis revealed that the proteins were organized in functional modules within the genome. Although most of the proteins have unknown functions, multiple proteins were associated with defense mechanisms against bacteria, including the restriction-modification system, the toxin-antitoxin system, evasion of DNA degradation, blocking of host restriction and modification, the orphan CRISPR-Cas system, and the anti-CRISPR system. Proteomic study of the phage-host interactions (i.e., between isolates K3574 and K3320, which have intact CRISPR-Cas systems, and phages vB_KpnS-VAC35 and vB_KpnM-VAC36, respectively) revealed the presence of several defense mechanisms against phage infection (prophage, defense/virulence/resistance, oxidative stress and plasmid proteins) in the bacteria, and of the Acr candidate (anti-CRISPR protein) in the phages. IMPORTANCE Researchers, including microbiologists and infectious disease specialists, require more knowledge about the interactions between phages and their bacterial hosts and about their defense mechanisms. In this study, we analyzed the molecular mechanisms of viral and bacterial defense in phages infecting clinical isolates of K. pneumoniae. Viral defense mechanisms included restriction-modification system evasion, the toxin-antitoxin (TA) system, DNA degradation evasion, blocking of host restriction and modification, and resistance to the abortive infection system, anti-CRISPR and CRISPR-Cas systems. Regarding bacterial defense mechanisms, proteomic analysis revealed expression of proteins involved in the prophage (FtsH protease modulator), plasmid (cupin phosphomannose isomerase protein), defense/virulence/resistance (porins, efflux pumps, lipopolysaccharide, pilus elements, quorum network proteins, TA systems, and methyltransferases), oxidative stress mechanisms, and Acr candidates (anti-CRISPR protein). The findings reveal some important molecular mechanisms involved in the phage-host bacterial interactions; however, further study in this field is required to improve the efficacy of phage therapy.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipThis study was funded by grant PI19/00878 and PI22/00323 awarded to M.T. within the State Plan for R1D1I 2013-2016 (National Plan for Scientific Research, Technological Development, and Innovation 2008-2011) and cofinanced by the ISCIII-Deputy General Directorate for Evaluation and Promotion of Research/European Regional Development Fund “A Way of Making Europe” and Instituto de Salud Carlos III FEDER, Spanish Network for the Research in Infectious Diseases (REIPI; RD16/0016/0006 and RD16/0016/0008), CIBERINFEC (CIBER21/13/00012, CB21/13/00049, CIBER21/13/00084, and CIBER21/13/00095), and Personalized Medicine Project (MePRAM; PMP/00092) and also by the Study Group on Mechanisms of Action and Resistance to Antimicrobials, GEMARA (SEIMC; http://www.seimc.org/). M.T. was financially supported by the Miguel Servet Research Program (SERGAS and ISCIII). I.B. was financially supported by pFIS program (ISCIII, FI20/00302). O.P., L.F.-G., and M.L. were financially supported by grants IN606A-2020/035, IN606B-2021/013, and IN606C-2022/002, respectively (GAIN; Xunta de Galicia). The authors acknowledge CESGA (www.cesga.es) in Santiago de Compostela, Spain, for providing access to computing facilities and the RIAIDT-USC analytical facilities. Finally, We thank researchers from the Spanish Network of Bacteriophages and Transducer Elements (FAGOMA) for contributing the lytic phages. I.B., L.B., O.P., and L.F.-G. developed the experiments, analyzed the results, and wrote the original manuscript. M.L., C.O.C. and A.B.P. helped to prepare the visual presentation of the results. F.F.C., Á.P., L.M.-M., and J.O.-I. rewrote the manuscript. M.T. financed and directed the experiments and supervised the writing of the originalmanuscript. We declare that there are no conflicts of interest.es_ES
dc.format.number2es_ES
dc.format.pagee0397422es_ES
dc.format.volume11es_ES
dc.identifier.citationMicrobiol Spectr. 2023 Mar 6;11(2):e0397422.es_ES
dc.identifier.doi10.1128/spectrum.03974-22es_ES
dc.identifier.e-issn2165-0497es_ES
dc.identifier.journalMicrobiology spectrumes_ES
dc.identifier.pubmedID36877024es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/16282
dc.language.isoenges_ES
dc.publisherAmerican Society for Microbiology (ASM)
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/MINECO//RD16%2F0016%2F0006/ES/RED ESPAÑOLA DE INVESTIGACIÓN EN PATOLOGÍAS INFECCIOSAS/es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/MINECO//RD16%2F0016%2F0008/ES/RED ESPAÑOLA DE INVESTIGACIÓN EN PATOLOGÍAS INFECCIOSAS/es_ES
dc.relation.projectFISinfo:fis/Instituto de Salud Carlos III/Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I/Subprograma Estatal de Generación de Conocimiento/PI19 - Proyectos de investigacion en salud (AES 2019). Modalidad proyectos en salud. (2019)/PI19/00878es_ES
dc.relation.projectFISinfo:fis/Instituto de Salud Carlos III///PI22- Proyectos de I+D+I en salud (AES 2022). (2022)/PI22/00323es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/FI20/00302es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/CIBER21/13/00012es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/CB21/13/00049es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/CIBER21/13/00084es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/CIBER21/13/00095es_ES
dc.relation.publisherversionhttps://doi.org/10.1128/spectrum.03974-22es_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectKlebsiella pneumoniaees_ES
dc.subjectLytic phagees_ES
dc.subjectPhage-host interactiones_ES
dc.subjectDefense mechanismes_ES
dc.subjectProphagees_ES
dc.subjectPlasmides_ES
dc.subjectKlebsiellaes_ES
dc.subjectBacteriophage evolutiones_ES
dc.subjectBacteriophagees_ES
dc.subjectVirus-host interactionses_ES
dc.titleProteomic Study of the Interactions between Phages and the Bacterial Host Klebsiella pneumoniaees_ES
dc.typeresearch articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication4ac67376-8b3e-48bd-9415-8770421fdd67
relation.isAuthorOfPublication.latestForDiscovery4ac67376-8b3e-48bd-9415-8770421fdd67
relation.isFunderOfPublication0e5401ef-8ce7-439f-85e0-4e3550b5fade
relation.isFunderOfPublication7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isFunderOfPublicationefa64f05-b985-4984-8f1e-5fc4ef21f502
relation.isFunderOfPublication59c823cb-42b5-4b1b-a401-bf53ee82c170
relation.isFunderOfPublication0b5a6d3a-4d4d-4346-9bcc-9359bbe13e72
relation.isFunderOfPublication3d2eadbc-cf2c-4663-8d3d-220eb217da68
relation.isFunderOfPublication.latestForDiscovery0e5401ef-8ce7-439f-85e0-4e3550b5fade
relation.isPublisherOfPublication30cd8aef-e018-40d1-b05e-19af778995bd
relation.isPublisherOfPublication.latestForDiscovery30cd8aef-e018-40d1-b05e-19af778995bd

Files

Original bundle

Now showing 1 - 4 of 4
Loading...
Thumbnail Image
Name:
ProteomicStudyInteractionsPhages_2023.pdf
Size:
3.71 MB
Format:
Adobe Portable Document Format
Description:
Articulo
Loading...
Thumbnail Image
Name:
Supplement1_ProteomicStudyInteractionsPhages_2023.pdf
Size:
55.25 KB
Format:
Adobe Portable Document Format
Description:
Supplementary material 1
Loading...
Thumbnail Image
Name:
Supplement2_ProteomicStudyInteractionsPhages_2023.xlsx
Size:
60.74 KB
Format:
Microsoft Excel XML
Description:
Supplementary material 2
Loading...
Thumbnail Image
Name:
Supplement3_ProteomicStudyInteractionsPhages_2023.xlsx
Size:
57.71 KB
Format:
Microsoft Excel XML
Description:
Supplementary material 3